Caligan Partners LP 13D and 13G filings for Alimera Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-09-18 4:30 pm Sale | 2024-09-16 | 13D | Alimera Sciences, Inc. ALIM | Caligan Partners LP | 0 0.000% | -17,635,154 (Position Closed) | Filing |
| 2024-06-24 7:30 pm Unchanged | 2024-06-21 | 13D | Alimera Sciences, Inc. ALIM | Caligan Partners LP | 17,635,154 33.200% | 0 (Unchanged) | Filing |
| 2023-08-03 4:30 pm Sale | 2023-08-01 | 13D | Alimera Sciences, Inc. ALIM | Caligan Partners LP | 17,635,154 33.100% | -915,040,279,903 (-100.00%) | Filing |
| 2023-05-18 5:24 pm Purchase | 2023-05-17 | 13D | Alimera Sciences, Inc. ALIM | Caligan Partners LP | 915,057,915,057 9.990% | 915,057,190,341 (+126264245.63%) | Filing |
| 2023-03-28 5:00 pm Purchase | 2023-03-24 | 13D | Alimera Sciences, Inc. ALIM | Caligan Partners LP | 724,716 9.990% | 313,189 (+76.10%) | Filing |
| 2022-05-25 5:18 pm Purchase | 2022-05-19 | 13D | Alimera Sciences, Inc. ALIM | Caligan Partners LP | 411,527 5.900% | 411,527 (New Position) | Filing |